191 related articles for article (PubMed ID: 30684188)
1. Evaluation of serum level of substance P and tissue distribution of NK-1 receptor in breast cancer.
Davoodian M; Boroumand N; Mehrabi Bahar M; Jafarian AH; Asadi M; Hashemy SI
Mol Biol Rep; 2019 Feb; 46(1):1285-1293. PubMed ID: 30684188
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of serum level of substance P and tissue distribution of NK-1 receptor in colorectal cancer.
Lorestani S; Ghahremanloo A; Jangjoo A; Abedi M; Hashemy SI
Mol Biol Rep; 2020 May; 47(5):3469-3474. PubMed ID: 32277443
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of serum level of substance P and tissue distribution of NK-1 receptor in endometrial cancer.
Gharaee N; Pourali L; Jafarian AH; Hashemy SI
Mol Biol Rep; 2018 Dec; 45(6):2257-2262. PubMed ID: 30225581
[TBL] [Abstract][Full Text] [Related]
4. Expression of substance P, neurokinin 1 receptor, Ki-67 and pyruvate kinase M2 in hormone receptor negative breast cancer and evaluation of impact on overall survival.
Al-Keilani MS; Bdeir R; Elstaty RI; Alqudah MA
BMC Cancer; 2023 Feb; 23(1):158. PubMed ID: 36797689
[TBL] [Abstract][Full Text] [Related]
5. Differential consequences of neurokinin receptor 1 and 2 antagonists in metastatic breast carcinoma cells; Effects independent of Substance P.
Nizam E; Erin N
Biomed Pharmacother; 2018 Dec; 108():263-270. PubMed ID: 30223097
[TBL] [Abstract][Full Text] [Related]
6. Up-regulated expression of substance P in CD8
Zhang Z; Zheng W; Xie H; Chai R; Wang J; Zhang H; He S
J Transl Med; 2017 May; 15(1):93. PubMed ID: 28460633
[TBL] [Abstract][Full Text] [Related]
7. The SP/NK1R system promotes the proliferation of breast cancer cells through NF-κB-mediated inflammatory responses.
Jafarinezhad S; Assaran Darban R; Javid H; Hashemy SI
Cell Biochem Biophys; 2023 Dec; 81(4):787-794. PubMed ID: 37740877
[TBL] [Abstract][Full Text] [Related]
8. Hepatoblastoma cells express truncated neurokinin-1 receptor and can be growth inhibited by aprepitant in vitro and in vivo.
Berger M; Neth O; Ilmer M; Garnier A; Salinas-Martín MV; de Agustín Asencio JC; von Schweinitz D; Kappler R; Muñoz M
J Hepatol; 2014 May; 60(5):985-94. PubMed ID: 24412605
[TBL] [Abstract][Full Text] [Related]
9. Roles of full-length and truncated neurokinin-1 receptors on tumor progression and distant metastasis in human breast cancer.
Zhou Y; Zhao L; Xiong T; Chen X; Zhang Y; Yu M; Yang J; Yao Z
Breast Cancer Res Treat; 2013 Jul; 140(1):49-61. PubMed ID: 23807418
[TBL] [Abstract][Full Text] [Related]
10. Tachykinin NK1 receptor antagonist L-733,060 and substance P deletion exert neuroprotection through inhibiting oxidative stress and cell death after traumatic brain injury in mice.
Li Q; Wu X; Yang Y; Zhang Y; He F; Xu X; Zhang Z; Tao L; Luo C
Int J Biochem Cell Biol; 2019 Feb; 107():154-165. PubMed ID: 30593954
[TBL] [Abstract][Full Text] [Related]
11. New insight into the role of substance P/neurokinin-1 receptor system in breast cancer progression and its crosstalk with microRNAs.
Ebrahimi S; Javid H; Alaei A; Hashemy SI
Clin Genet; 2020 Oct; 98(4):322-330. PubMed ID: 32266968
[TBL] [Abstract][Full Text] [Related]
12. Immunolocalization of Substance P and NK-1 Receptor in ADIPOSE Stem Cells.
Muñoz M; Muñoz MF; Ayala A
J Cell Biochem; 2017 Dec; 118(12):4686-4696. PubMed ID: 28500728
[TBL] [Abstract][Full Text] [Related]
13. MiR-34b/c-5p and the neurokinin-1 receptor regulate breast cancer cell proliferation and apoptosis.
Zhang L; Wang L; Dong D; Wang Z; Ji W; Yu M; Zhang F; Niu R; Zhou Y
Cell Prolif; 2019 Jan; 52(1):e12527. PubMed ID: 30334298
[TBL] [Abstract][Full Text] [Related]
14. Upregulated expression of substance P (SP) and NK1R in eczema and SP-induced mast cell accumulation.
Zhan M; Zheng W; Jiang Q; Zhao Z; Wang Z; Wang J; Zhang H; He S
Cell Biol Toxicol; 2017 Aug; 33(4):389-405. PubMed ID: 28154998
[TBL] [Abstract][Full Text] [Related]
15. [Increased expressions of substance P and neurokinin/tachykinin receptor 1 in eosinophils of patients with psoriasis].
Zuo Z; Wang J; Zhang H; Zheng W; Zhang Z; He S
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2017 Jul; 33(7):966-970. PubMed ID: 28712406
[TBL] [Abstract][Full Text] [Related]
16. High expression of substance P and its receptor neurokinin-1 receptor in colorectal cancer is associated with tumor progression and prognosis.
Chen XY; Ru GQ; Ma YY; Xie J; Chen WY; Wang HJ; Wang SB; Li L; Jin KT; He XL; Mou XZ
Onco Targets Ther; 2016; 9():3595-602. PubMed ID: 27366097
[TBL] [Abstract][Full Text] [Related]
17. Substance P and the neurokinin-1 receptor expression in dog ileum with and without inflammation.
Polidoro G; Giancola F; Fracassi F; Pietra M; Bettini G; Asti M; Chiocchetti R
Res Vet Sci; 2017 Oct; 114():297-307. PubMed ID: 28628846
[TBL] [Abstract][Full Text] [Related]
18. Normative distribution of substance P and its tachykinin neurokinin-1 receptor in the medullary serotonergic network of the human infant during postnatal development.
Bright FM; Byard RW; Vink R; Paterson DS
Brain Res Bull; 2018 Mar; 137():319-328. PubMed ID: 29331576
[TBL] [Abstract][Full Text] [Related]
19. Role of Substance P and Its Receptor Neurokinin 1 in Chronic Prurigo: A Randomized, Proof-of-Concept, Controlled Trial with Topical Aprepitant.
Ohanyan T; Schoepke N; Eirefelt S; Hoey G; Koopmann W; Hawro T; Maurer M; Metz M
Acta Derm Venereol; 2018 Jan; 98(1):26-31. PubMed ID: 28853492
[TBL] [Abstract][Full Text] [Related]
20. SP promotes cell proliferation in esophageal squamous cell carcinoma through the NK1R/Hes1 axis.
Wang F; Liu S; Liu J; Feng F; Guo Y; Zhang W; Zheng G; Wang Q; Cai L; Guo M; Lian X; Xu G; Zhang H
Biochem Biophys Res Commun; 2019 Jul; 514(4):1210-1216. PubMed ID: 31109645
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
